RAINBOW - IntraDay Trade Analysis

Last Updated Time : 02 Aug 25, 12:58 am

IntraDay Trade Rating: 3.8

RAINBOW offers a promising technical structure with upward bias, though tempered by light volume and a rich valuation. It’s best approached as a moderate-risk intraday opportunity, ideal for swift scalping near key levels or breakout plays if momentum improves mid-session.

⚙️ Technical Overview

Current Price: ₹1,525

Trading above DMA 50 (₹1,491) and DMA 200 (₹1,421) → Supports bullish undertone

RSI: 50.4 → Midline, neutral but poised for strength if buying resumes

MACD: +17.6 → Bullish crossover in play; favorable for continuation setups

Volume: 83K vs Avg 3.65L → Light participation may affect intraday range

💡 Intraday Trading Strategy

✅ For fresh entry

Buy Zone: ₹1,520–₹1,525 on early dip or consolidation near support

Targets

₹1,545 → conservative exit (mild resistance zone)

₹1,565 → extended target if RSI pushes above 54 and MACD slope steepens

Stop-Loss: ₹1,510

🔄 If already holding

Hold only if price remains above ₹1,518

Partial Exit near ₹1,545 if RSI plateaus or volume weakens

Full Exit near ₹1,565 if candles show upper wicks or MACD flattens

Exit below ₹1,510 if RSI dips under 49 or red candles dominate volume

🧮 Fundamental Factors

EPS: ₹25.4, P/E: 60.3 vs Industry PE: 69.2 → Richly priced but aligned with sector valuation

ROCE/ROE: 18.7% / 17.4% → Solid efficiency metrics

Debt-to-Equity: 0.52 → Reasonably healthy balance sheet

Qtr Profit Var: 35.3% → Strong earnings momentum

Institutional Activity: Flat → Low FII interest, marginal DII buying

RAINBOW has just enough technical spark to justify a short-term tactical trade today. Execution precision matters here—wait for dips or signs of strength before committing. If you’d like to compare it to other healthcare stocks with tighter valuation and better volume, I can pull up a fresh watchlist for you too 🩺📊.

Edit in a page